Oncogenic Signaling Pathways in The Cancer Genome Atlas

Journal: Cell

Published: 2018-04-05

DOI: 10.1016/j.cell.2018.03.035

Affiliations: 41

Authors: 54

Go to article
Institutions FC
Marie-Josée and Henry R. Kravis Center for Molecular Oncology, MSKCC, United States of America (USA) 0.23
Van Andel Research Institute (VAI), United States of America (USA) 0.06
Department of Computer Engineering, Bilkent University, Turkey 0.06
John T. Milliken Department of Medicine, WUSTL, United States of America (USA) 0.04
McDonnell Genome Institute (MGI), WUSTL, United States of America (USA) 0.04
Cancer Area, Broad Institute, United States of America (USA) 0.04
Department of Systems Pharmacology and Translational Therapeutics, Penn, United States of America (USA) 0.04
Bobby R. Alford Department of Otolaryngology - Head and Neck Surgery, BCM, United States of America (USA) 0.04
UCSF Helen Diller Family Comprehensive Cancer Center, United States of America (USA) 0.04
Department of Medical Oncology, DFCI, United States of America (USA) 0.04
Department of Computational Biology, UNIL, Switzerland 0.02
Human Oncology and Pathogenesis Program (HOPP), MSKCC, United States of America (USA) 0.02
Department of Translational Molecular Pathology, MD Anderson Cancer Center, United States of America (USA) 0.02
Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, United States of America (USA) 0.02
Swiss Institute of Bioinformatics (SIB), Switzerland 0.02
The University of Texas at Dallas (UT Dallas), United States of America (USA) 0.02
Princeton University, United States of America (USA) 0.02
Harvard Department of Cell Biology, United States of America (USA) 0.02
Institute for Systems Biology (ISB), United States of America (USA) 0.02
TESARO, Inc., United States of America (USA) 0.02
Center for Biomedical Imaging in Oncology (CBIO), DFCI, United States of America (USA) 0.02
Human Biology Division, FHCRC, United States of America (USA) 0.02
UCSF Department of Otolaryngology-Head and Neck Surgery (OHNS), United States of America (USA) 0.02
Rogel Cancer Center, U-M, United States of America (USA) 0.02
Division of Metabolism, Endocrinology and Diabetes (MEND), U-M, United States of America (USA) 0.02
Peter MacCallum Cancer Centre (Peter Mac), Australia 0.01
Mayo Clinic Department of Health Sciences Research (HSR), United States of America (USA) 0.01
Mayo Clinic Department of Obstetrics and Gynecology, United States of America (USA) 0.01
The University of Melbourne (UniMelb), Australia 0.01
Department of Pathology, U-M, United States of America (USA) 0.01
Department of Genomic Medicine, MD Anderson Cancer Center, United States of America (USA) 0.01
Department of Epidemiology and Biostatistics, MSKCC, United States of America (USA) 0.01
Department of Pathology, MD Anderson Cancer Center, United States of America (USA) 0.01
Siteman Cancer Center, WUSTL, United States of America (USA) 0.01
Department of Pathology and Cell Biology, CU, United States of America (USA) 0.01
Institute for Cancer Genetics (ICG), CU, United States of America (USA) 0.01
Department of Neurology, CU, United States of America (USA) 0.01

Return